Genetix Biotech Asia Limited - Company Profile

Q: Who are the current directors of Genetix Biotech Asia Limited?

The current directors of Genetix Biotech Asia Limited are Arun Prakash, Raminder Kaur, Navin Chandra Khanna, Sandeep Aggarwal, Sunil Kumar, Samuel John Farrimond, Rakesh Kumar Dubey, Poonam Deep, Sandeep Aggarwal.

It is a healthcare public limited company based in Delhi, Delhi, India, established in 2001.

2001 Delhi, Delhi, India Active

Last Updated: December 21, 2025

Access Report

About Genetix Biotech Asia Limited

Genetix Biotech Asia Limited, a active public limited company, was established on 10 October 2001 in Delhi, Delhi, India. Engaging in medical & laboratory equipment within the trade sector, it holds CIN: U24239DL2001PLC112768. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹10.65 Cr.

It upholds a compliant status. Employing 127 professional, Its leadership includes Arun Prakash (Managing Director), Raminder Kaur (Whole-Time Director), Navin Chandra Khanna (Director). Past directors included Arun Prakash, Raminder Kaur, Kailash Parkash. It holds ₹118.69 Cr open charges and ₹64.30 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at House No.71/1, First Floor, Shivaji Marg, Najafgarh Road, Delhi, Delhi, 110015.

Company Details

CIN/LLPIN
U24239DL2001PLC112768
Registration Number
112768
Incorporation Date
10 October 2001
Authorized Capital
₹15.00 Cr
Paid-Up Capital
₹10.65 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 15.00 Cr as on 21-12-2025
Paid Up Capital ₹ 10.65 Cr as on 21-12-2025
Company Age 24 Year, 4 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 118.69 Cr as on 21-12-2025
Satisfied Charges ₹ 64.30 Cr as on 21-12-2025
Revenue Growth **** -53.23% (FY 2023)
Profit Growth **** -74.30% (FY 2023)
Ebitda **** -72.89% (FY 2023)
Net Worth 10.30% (FY 2023)
Total Assets **** 1.60% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Genetix Biotech Asia Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Genetix Biotech Asia Limited?

Current Directors

Name	Designation	Appointment Date	Status
Arun Prakash	Managing Director	10 Oct 2001	Current
Raminder Kaur	Whole-Time Director	10 Oct 2001	Current
Navin Chandra Khanna	Director	08 Feb 2025	Current
Sandeep Aggarwal	Cfo	29 Jul 2024	Current
Samuel John Farrimond	Director	11 Dec 2024	Current
Rakesh Kumar Dubey	Director	18 Nov 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	05 Sep 2024	Past
Pramod Abcsdd	Director	05 Sep 2024	Past
Pramod Abcsdd	Director	05 Oct 2018	Past
Pramod Abcsdd	Additional Director	28 Dec 2024	Past
Pramod Abcsdd	Additional Director	18 Mar 2025	Past
Pramod Abcsdd	Additional Director	29 Dec 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genetix Biotech Asia.

Genetix Biotech Asia Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.23% decrease. The company also saw a substantial fall in profitability, with a 74.3% decrease in profit. The company's net worth Soared by an impressive increase of 10.3%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-53.23%

*******

Revenue from Operations

*******

-53.54%

*******

Total Assets

*******

1.60%

*******

Profit or Loss

*******

-74.30%

*******

Net Worth

*******

10.30%

*******

EBITDA

*******

-72.89%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genetix Biotech Asia?

In 2023, Genetix Biotech Asia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,186,921,201.00

Satisfied Charges

₹642,950,000.00

Charges Breakdown by Lending Institutions

Others : 65.86 Cr
Hdfc Bank Limited : 27.83 Cr
Citi Bank N.A. : 25.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Sep 2025	Others	₹25.00 Cr	Open
10 Aug 2024	Others	₹8.00 M	Open
24 Jan 2024	Others	₹11.06 Cr	Open
04 Jan 2024	Hdfc Bank Limited	₹0.46 M	Open
18 Jan 2023	Hdfc Bank Limited	₹1.21 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Genetix Biotech Asia?

Genetix Biotech Asia has a workforce of 127 employees as of Jan 13, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Genetix Biotech Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetix Biotech Asia's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genetix Biotech Asia

Recent Activity within the Organization

Charges

A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101178681 was registered on 26 Sep 2025. was recorded as a recent event.
26 Sep 2025
Director Appointment

Progress on Navin Chandra Khanna was appointed as a Director was appointed as a Director on 08 Feb 2025 & has been associated with this company since 1 year 15 days . was documented.
08 Feb 2025
Annual General Meeting

Genetix Biotech Asia Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was recorded as a recent event.
30 Dec 2024
Director Appointment

Samuel John Farrimond was appointed as a Director was appointed as a Director on 11 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
11 Dec 2024
Director Appointment

The activity Rakesh Kumar Dubey was appointed as a Director was appointed as a Director on 18 Nov 2024 & has been associated with this company since 1 year 3 months . was completed.
18 Nov 2024
Charges

Progress on A charge with Citi Bank N.A. of Rs. 25.00 Cr registered on 18 Aug 2020 with Charge ID 100360156 was modified on 06 Nov 2024. was documented.
06 Nov 2024

Explore recent activity and updates - View Recent Activity